-
1 Comment
Qingdao Haier Biomedical Co., Ltd is currently in a long term uptrend where the price is trading 29.9% above its 200 day moving average.
From a valuation standpoint, the stock is 126.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.8.
Qingdao Haier Biomedical Co., Ltd's total revenue rose by 48.0% to $421M since the same quarter in the previous year.
Its net income has increased by 122.7% to $109M since the same quarter in the previous year.
Finally, its free cash flow grew by 246.3% to $253M since the same quarter in the previous year.
Based on the above factors, Qingdao Haier Biomedical Co., Ltd gets an overall score of 4/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Medical Devices |
| ISIN | CNE100003P25 |
| Target Price | 80 |
|---|---|
| Dividend Yield | 1.5% |
| Beta | 0.66 |
| Market Cap | 10B |
| PE Ratio | 39.11 |
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, transport coolers, and RTMD products; and CO2 incubation, standard incubators, biological safety cabinets, clean benches and laminar, and sterilization products. It also provides floor standing, benchtop refrigerated, and benchtop centrifuges; intelligent pharmacy automation and RFID pharmacy products; blood bank refrigerators, blood component management products, blood plasma freezers, and transport coolers; and vaccine storage, cold/freezer room, medical waste disposal equipment, and other products. In addition, the company offers freezer and controlled rate freezers; UV visible spectrophotometer and total organic carbon analyzer products; and consumables. Further, it provides after-sales services; and U-biobank, U-vaccine, U-reagent, U-blood, and U-laboratory network solutions. The company serves hospitals, bio-pharmaceutical enterprises, universities and colleges, scientific research institutions, centers for disease control, and blood stations. Qingdao Haier Biomedical Co.,Ltd was founded in 2005 and is based in Qingdao, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688139.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
